Axogen share price today

Name: Axogen Share Price Today (NASDAQ: AXGN) - Axogen Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

(AXGN)

Axogen share price is $18.92 & ₹1,637.81 as on 22 Jan 2025, 2.30 'hrs' IST

$18.92

▲

0.83

(4.59%)

Market is closed - opens 8 PM, 22 Jan 2025

View live Axogen share price in Dollar and Rupees. Guide to invest in Axogen stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Axogen, along with analyst recommendations, forecasts, and comprehensive financials.

Axogen share price movements

Today's Low: $18.23
Today's High: $19.00
$18.92
3.65%
Downside
Day's Volatility :4.03%
Upside
0.39%
52 Weeks Low: $5.55
52 Weeks High: $18.96
$18.92
70.67%
Downside
52 Weeks Volatility :70.73%
Upside
0.21%

Axogen Returns

Period	Axogen, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	37.88%	-7.4%	0.0%
6 Months	95.15%	-5.2%	0.0%
1 Year	104.18%	0.5%	0.0%
3 Years	109.86%	8.3%	-11.0%

Axogen Key Statistics

in dollars & INR

Previous Close	$18.09
Open	$18.2
Today's High	$18.995
Today's Low	$18.23
Market Capitalization	$796.1M
Today's Volume	$490.4K
52 Week High	$18.995
52 Week Low	$5.55
Revenue TTM	$180.9M
EBITDA	$-1.8M
Earnings Per Share (EPS)	$-0.33
Profit Margin	-7.91%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-14.51%

How to invest in Axogen from India?

It is very easy for Indian residents to invest directly in Axogen from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Axogen stock in both Indian Rupees (INR) and US Dollars (USD). Search for Axogen or AXGN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Axogen or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Axogen shares which would translate to 0.046 fractional shares of Axogen as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Axogen, in just a few clicks!

Returns in Axogen for Indian investors in Rupees

Investment Value

₹1,00,000

Axogen investment value today

Current value as on today

₹2,17,674

Returns

₹1,17,674

(+117.67%)

Returns from Axogen Stock

₹1,13,544 (+113.54%)

Dollar Returns

₹4,130 (+4.13%)

Indian investors sentiment towards Axogen

228%

Period: Oct 23, 2024 to Jan 21, 2025. Change in 30 Days versus previous period

Search volume for Axogen on INDmoney from India has grown in the last 30 days as on Jan 22, 2025. 228% more investors are searching Axogen in the last 30 days versus the previous period.

Global Institutional Holdings in Axogen

First Light Asset Management, LLC
9.29%
BlackRock Inc
7.75%
Soleus Capital Management, L.P.
6.83%
Morgan Stanley - Brokerage Accounts
6.59%
Vanguard Group Inc
5.51%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
5.17%

Analyst Recommendation on Axogen

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Axogen(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Axogen

What analysts predicted

Downside of 2.22%

Target:

$18.50

Current:

$18.92

Insights on Axogen

Price Movement
In the last 3 months, AXGN stock has moved up by 37.6%
Increasing Revenue
Revenue is up for the last 3 quarters, 41.37M → 48.64M (in $), with an average increase of 7.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -6.63M → -1.85M (in $), with an average increase of 124.4% per quarter
AXGN vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 129.6% return, outperforming this stock by 11.1%

Axogen Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$83.9M	↑ 38.91%
Net Income	$-22.4M	↑ 114.42%
Net Profit Margin	-26.68%	↓ 9.39%

	FY19	Y/Y Change
Revenue	$106.7M	↑ 27.13%
Net Income	$-29.1M	↑ 30.03%
Net Profit Margin	-27.29%	↓ 0.61%

	FY20	Y/Y Change
Revenue	$112.3M	↑ 5.24%
Net Income	$-24.8M	↓ 14.83%
Net Profit Margin	-22.09%	↑ 5.2%

	FY21	Y/Y Change
Revenue	$127.4M	↑ 13.41%
Net Income	$-28.1M	↑ 13.15%
Net Profit Margin	-22.03%	↑ 0.06%

	FY22	Y/Y Change
Revenue	$138.6M	↑ 8.81%
Net Income	$-27.3M	↓ 2.59%
Net Profit Margin	-19.72%	↑ 2.31%

	FY23	Y/Y Change
Revenue	$159.0M	↑ 14.74%
Net Income	$-21.7M	↓ 20.56%
Net Profit Margin	-13.66%	↑ 6.06%

	Q2 FY23	Q/Q Change
Revenue	$38.2M	↑ 4.07%
Net Income	$-6.7M	↓ 0.75%
Net Profit Margin	-17.46%	↑ 0.84%

	Q3 FY23	Q/Q Change
Revenue	$41.3M	↑ 8.17%
Net Income	$-4.1M	↓ 38.6%
Net Profit Margin	-9.91%	↑ 7.55%

	Q4 FY23	Q/Q Change
Revenue	$42.9M	↑ 4.0%
Net Income	$-3.9M	↓ 4.79%
Net Profit Margin	-9.07%	↑ 0.84%

	Q1 FY24	Q/Q Change
Revenue	$41.4M	↓ 3.6%
Net Income	$-6.6M	↑ 70.43%
Net Profit Margin	-16.04%	↓ 6.97%

	Q2 FY24	Q/Q Change
Revenue	$47.9M	↑ 15.79%
Net Income	$-1.9M	↓ 71.05%
Net Profit Margin	-4.01%	↑ 12.03%

	Q3 FY24	Q/Q Change
Revenue	$48.6M	↑ 1.53%
Net Income	$-1.9M	↓ 3.28%
Net Profit Margin	-3.82%	↑ 0.19%

	FY18	Y/Y Change
Profit	$71.0M	↑ 38.93%

	FY19	Y/Y Change
Profit	$89.4M	↑ 25.84%

	FY20	Y/Y Change
Profit	$90.7M	↑ 1.52%

	FY21	Y/Y Change
Profit	$104.4M	↑ 15.11%

	FY22	Y/Y Change
Profit	$114.4M	↑ 9.59%

	FY23	Y/Y Change
Profit	$127.9M	↑ 11.74%

	Q2 FY23	Q/Q Change
Profit	$30.9M	↑ 3.24%

	Q3 FY23	Q/Q Change
Profit	$33.2M	↑ 7.44%

	Q4 FY23	Q/Q Change
Profit	$33.8M	↑ 1.61%

	Q1 FY24	Q/Q Change
Profit	$32.6M	↓ 3.39%

	Q2 FY24	Q/Q Change
Profit	$35.3M	↑ 8.35%

	Q3 FY24	Q/Q Change
Profit	$36.4M	↑ 3.09%

	FY18	Y/Y Change
Operating Cash Flow	$-17.9M	↑ 93.36%
Investing Cash Flow	$-98.2M	↑ 7498.8%
Financing Cash Flow	$109.8M	↑ 545.29%

	FY19	Y/Y Change
Operating Cash Flow	$-19.9M	↑ 11.25%
Investing Cash Flow	$27.3M	↓ 127.77%
Financing Cash Flow	$4.0M	↓ 96.33%

	FY20	Y/Y Change
Operating Cash Flow	$-9.6M	↓ 51.56%
Investing Cash Flow	$-17.0M	↓ 162.2%
Financing Cash Flow	$40.5M	↑ 904.07%

	FY21	Y/Y Change
Operating Cash Flow	$-13.4M	↑ 39.26%
Investing Cash Flow	$-23.6M	↑ 39.42%
Financing Cash Flow	$20.5M	↓ 49.47%

	FY22	Y/Y Change
Operating Cash Flow	$-16.1M	↑ 19.85%
Investing Cash Flow	$-3.2M	↓ 86.47%
Financing Cash Flow	$1.8M	↓ 91.23%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$292.0K	↓ 103.93%
Investing Cash Flow	$14.3M	↓ 1922.14%
Financing Cash Flow	$898.0K	↑ 41.86%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$1.6M	↑ 456.85%
Investing Cash Flow	$6.0M	↓ 58.15%
Financing Cash Flow	$5.0K	↓ 99.44%

Axogen Technicals Summary

Sell

Neutral

Buy

Axogen is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Axogen Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Axogen, Inc.	5.24%	95.15%	104.18%	109.86%	47.79%
Medtronic Plc	8.21%	10.14%	2.02%	-15.48%	-26.14%
Edwards Lifesciences Corp.	-6.72%	-19.75%	-6.75%	-36.91%	-9.16%
Boston Scientific Corp.	9.79%	26.88%	62.75%	131.27%	128.33%
Stryker Corporation	4.62%	12.63%	22.82%	52.2%	78.98%
Abbott Laboratories	-0.73%	5.8%	-0.46%	-8.35%	25.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Axogen, Inc.	NA	NA	0.0	0.08	-0.15	-0.03	NA	2.26
Medtronic Plc	26.94	26.94	1.5	5.45	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	26.94	26.94	6.41	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	81.54	81.54	1.79	2.46	0.09	0.05	NA	14.05
Stryker Corporation	41.14	41.14	2.68	12.06	0.19	0.07	0.01	52.86
Abbott Laboratories	34.49	34.49	2.2	4.67	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Axogen, Inc.	Buy	$796.1M	47.79%	NA	-7.91%
Medtronic Plc	Buy	$112.9B	-26.14%	26.94	12.06%
Edwards Lifesciences Corp.	Buy	$41.2B	-9.16%	26.94	65.86%
Boston Scientific Corp.	Buy	$145.4B	128.33%	81.54	11.26%
Stryker Corporation	Buy	$146.2B	78.98%	41.14	16.34%
Abbott Laboratories	Buy	$196.8B	25.53%	34.49	13.99%

About Axogen

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.

Organization	Axogen
Employees	426
CEO	Mr. Nir Naor C.F.A., CPA, L.L.M., M.B.A.
Industry	Health Technology

Management People of Axogen

Name	Title
Mr. Nir Naor C.F.A., CPA, L.L.M., M.B.A.	Chief Financial Officer
Ms. Karen Zaderej	Advisor
Mr. Erick DeVinney	Chief Innovation Officer
Mr. Craig A. Swandal	Vice President of Operations
Mr. Harold D. Tamayo	Vice President of Finance & Investor Relations
Mr. Marc A. Began	Executive VP, General Counsel & Chief Compliance Officer
Ms. Doris Quackenbush	Vice President of Sales
Mr. Jens Schroeder Kemp	Chief Marketing Officer
Dr. Ivica Ducic M.D., Ph.D.	Chief Medical Officer

Important FAQs about investing in Axogen from India :

What is Axogen share price today?

Axogen share price today stands at $18.92, Open: $18.20 ; Previous Close: $18.09 ; High: $19.00 ; Low: $18.23 ; 52 Week High: $18.96 ; 52 Week Low: $5.55. The stock opens at $18.20, after a previous close of $18.09. The stock reached a daily high of $19.00 and a low of $18.23, with a 52-week high of $18.96 and a 52-week low of $5.55.

Can Indians buy Axogen shares?

Yes, Indians can invest in the Axogen (AXGN) from India.

With INDmoney, you can buy Axogen at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Axogen at zero transaction cost.

How can I buy Axogen shares from India?

It is very easy to buy Axogen from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Axogen be purchased?

Yes, you can buy fractional shares of Axogen with INDmoney app.

What are the documents required to start investing in Axogen stocks?

To start investing in Axogen, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.